Brief iPad-Based Assessment of Cognitive Functioning with ImPACT® Pediatric

ABSTRACT

ImPACT® Pediatric is an examiner-administered iOS-based battery of neuropsychological tests designed to measure neurocognitive functioning in children ages 5–11. This study documented Multivariate Base Rates (prevalence of low scores when multiple test scores are considered simultaneously) in the ImPACT® Pediatric standardization sample (N = 892). In the total sample, it was common for children to obtain at least one low factor score using the 25th percentile [T 43; base rate (BR) = 54.2%], 16th percentile (T40, BR = 38.1%), and the 10th percentile (T37, BR = 31.1%). However, it was uncommon for children to obtain two (or more) low factor scores using any of the above-listed cutoff score.

Conflict of Interest Declaration

Grant Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc.). He receives royalties from the WCST-64. He has received salary support from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. He acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation and ImPACT Applications, Inc. He has no commercial or proprietary interest in ImPACT® Pediatric. Philip Schatz has received funding from ImPACT Applications, Inc. He has no commercial or proprietary interest in ImPACT® Pediatric.